| 6.85 |  +0.62 / +9.95% |
Data as of May 23 | Day’s Change |
| 6.80 |  -0.05 / -0.73% |
Volume: 400.8K |
| 4 Hot Stocks to Trade (or Not) May 23 / TheStreet.com | Narrower-than-Expected Loss at MannKind - Analyst Blog May 13 / Zacks.com |
| Commit To Buy MannKind Corp At $2.50, Earn 28% May 23 / TheStreet.com |
| Previous close | 6.23 |
| Today’s open | 6.50 |
| Day’s range | -- - -- |
| Volume | 19,997,543 |
| Average volume (3 months) | 6,119,044 |
| Market cap | $1.8B |
| Dividend yield | -- |
| Earnings growth (last year) | +28.79% |
| Earnings growth (this year) | +48.94% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | -30.00% |
| P/E ratio | NM |
| Price/Sales | 11,936.43 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| MDCOThe Medicines Co | +0.79 | +2.43% |
| ARNAArena Pharmaceutical... | +0.14 | +1.77% |
| VPHMViroPharma Inc | +0.34 | +1.30% |
| QCORQuestcor Pharmaceuti... | -0.72 | -2.00% |
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $35.0K |
| Annual profit (last year) | -$169.4M |
| Net profit margin | -483,902.86% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Alfred E. Mann |
President, Chief Operating Officer & Director Hakan S. Edstrom, MBA |
Corporate headquarters Valencia, California |
.
